PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34867416-9	2021	Importantly, supplementation with DHM significantly inhibited the release of nuclear factor kappa-B (NF-kappaB) signaling pathway and pro-inflammatory factors in liver tissue induced by TAA, and improved liver fiber diseases, such as tumor necrosis factor alpha (TNF-alpha) and recombinant rat IL-1beta (IL-1beta).	dihydromyricetin	34-37	tumor necrosis factor	Rattus norvegicus	234-261	
34867416-9	2021	Importantly, supplementation with DHM significantly inhibited the release of nuclear factor kappa-B (NF-kappaB) signaling pathway and pro-inflammatory factors in liver tissue induced by TAA, and improved liver fiber diseases, such as tumor necrosis factor alpha (TNF-alpha) and recombinant rat IL-1beta (IL-1beta).	dihydromyricetin	34-37	tumor necrosis factor	Rattus norvegicus	263-272	
30443190-3	2018	This study aims to explore the relevance of SIRT3 and OA, as well as the therapeutic effects of DHM on mitochondrial homeostasis in TNF-alpha-treated chondrocytes.	dihydromyricetin	96-99	tumor necrosis factor	Rattus norvegicus	132-141	
30443190-9	2018	Moreover, our study demonstrated that DHM might activate SIRT3 to protect rat chondrocytes from TNF-alpha-induced degeneration and protective effects of DHM on mitochondrial homeostasis in chondrocytes attributed to enhanced SIRT3.	dihydromyricetin	38-41	tumor necrosis factor	Rattus norvegicus	96-105	
23236762-1	2012	OBJECTIVE: To study the effects of dihydromyricetin (DMY) on tumor necrosis factor (TNF-alpha) and NF-kappaB p65 cells of the recurrent aphthous ulcer (RAU) rat.	dihydromyricetin	35-51	tumor necrosis factor	Rattus norvegicus	84-93	
23236762-1	2012	OBJECTIVE: To study the effects of dihydromyricetin (DMY) on tumor necrosis factor (TNF-alpha) and NF-kappaB p65 cells of the recurrent aphthous ulcer (RAU) rat.	dihydromyricetin	53-56	tumor necrosis factor	Rattus norvegicus	84-93	
23236762-14	2012	DMY and licorzine significantly reduced occurrence of oral mucosa ulcer in RAU rats, lowered content of TNF-alpha and the expression of TNF-alpha mRNA in serum and oral mucosa, reduced expression of positive NF-kappaB p65 cells and the amount of macrophages.	dihydromyricetin	0-3	tumor necrosis factor	Rattus norvegicus	104-113	
23236762-14	2012	DMY and licorzine significantly reduced occurrence of oral mucosa ulcer in RAU rats, lowered content of TNF-alpha and the expression of TNF-alpha mRNA in serum and oral mucosa, reduced expression of positive NF-kappaB p65 cells and the amount of macrophages.	dihydromyricetin	0-3	tumor necrosis factor	Rattus norvegicus	136-145	
30003825-16	2018	DMY decreased the serum level of NO, MDA, IL-1beta and TNF-alpha, which had increased in LPS rats.	dihydromyricetin	0-3	tumor necrosis factor	Rattus norvegicus	55-64